English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1244]
News [2385]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
Treatment options for newly diagnosed multiple myeloma and management of bone...
Prof Sonneveld, Prof Cavo, Prof Terpos and Professor Voorhees
Treatment options for newly diagnosed multiple myeloma and management of bone disease: Roundtable at IMW 2017 ( Prof Sonneveld, Prof Cavo, Prof Terpos and Professor Voorhees )
2 Mar 2017
Teaming up with competitors in HARMONY
Tayyab Salimullah - Novartis Oncology, Basel, Switzerland
Teaming up with competitors in HARMONY ( Tayyab Salimullah - Novartis Oncology, Basel, Switzerland )
13 Feb 2017
Views from the hospital: Medical oncology in Hong Kong
David Johnson- The Chinese University of Hong Kong, Hong Kong
Views from the hospital: Medical oncology in Hong Kong ( David Johnson- The Chinese University of Hong Kong, Hong Kong )
3 Jan 2017
State of the art in soft tissue sarcomas
Dr Axel Le Cesne - Gustave Roussy Institute of Oncology, France
State of the art in soft tissue sarcomas ( Dr Axel Le Cesne - Gustave Roussy Institute of Oncology, France )
21 Dec 2016
Modern modalities for treating local laryngeal cancers
Prof Lisa Licitra - Instituto Nazionale Tumori, Milan, Italy
Modern modalities for treating local laryngeal cancers ( Prof Lisa Licitra - Instituto Nazionale Tumori, Milan, Italy )
20 Dec 2016
Epirubicin and cyclophosphamide before docetaxel in early breast cancer
Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark
Epirubicin and cyclophosphamide before docetaxel in early breast cancer ( Dr Bent Ejlertsen - Rigshospitalet Copenhagen, Denmark )
14 Dec 2016
Matched mutations and long term letrozole for breast cancer
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA
Matched mutations and long term letrozole for breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, USA )
14 Dec 2016
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer
Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA
Oestrogen deprivation inffective with chemo for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )
13 Dec 2016
No benefit for adjuvant ibandronate at 3 years in early breast cancer
Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands
No benefit for adjuvant ibandronate at 3 years in early breast cancer ( Prof Sabine Linn - Netherlands Cancer Institute, Amsterdam, The Netherlands )
13 Dec 2016
Ibrutinib in CLL: RESONATE and resistance
Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA
Ibrutinib in CLL: RESONATE and resistance ( Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA )
4 Dec 2016
Updates from the EURO-SKI trial of tyrosine kinase cessation
Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
Updates from the EURO-SKI trial of tyrosine kinase cessation ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016
CML patients with stable response may safely decrease dose of TKI
Prof Mhairi Copland - University of Glasgow, Glasgow, UK
CML patients with stable response may safely decrease dose of TKI ( Prof Mhairi Copland - University of Glasgow, Glasgow, UK )
3 Dec 2016
<1...7374757677...104>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top